Position in DSGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,194,967
+$506,924 QoQ
Shares Held
300,279
+4.8% QoQ
Ownership
0.481%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,610,487,463 across 418 Biotechnology names. DSGN ranks #159 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in DSGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,194,967 | 300,279 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,688,043 | 286,572 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,232,861 | 296,529 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,221,682 | 362,518 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,442,298 | 373,653 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,394,729 | 388,125 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,811,843 | 336,774 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,130,104 | 337,345 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,439,852 | 357,284 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $988,254 | 372,927 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $762,890 | 323,259 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,045,849 | 324,738 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,591,179 | 275,768 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,863,872 | 279,130 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,743,380 | 283,695 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,612,308 | 258,022 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,408,198 | 211,034 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,539,240 | 212,015 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,804,401 | 122,832 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,695,630 | 135,527 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||